Vanderbilt Clinical Oncology Research Career Development Program
The Vanderbilt Clinical Oncology Research Career Development Program (VCORCDP) is a two-to-three-year training program for physicians interested in a career in clinical oncology research. The VCORCDP is funded through the National Institute of Health’s (NIH) Paul Calabresi K12 Training Grant Mechanism.
The goal of the VCORCDP is to train and support the career development of senior fellows and junior faculty to become successful clinical and translational investigators in oncology. The primary components of VCORCDP are:
- Completion of mentored clinical research in oncology
- Didactic work leading to an advanced degree or equivalent educational experience
- Career coaching in the conduct of robust, impactful, and collaborative science that advances the clinical care of patients with cancer
Senior Fellows in training or junior faculty (Instructors or Assistant Professors) interested in developing careers in clinical cancer research are eligible for Vanderbilt Clinical Oncology Research Career Development Program (VCORCDP). All clinicians must have completed their residency.
Potential scholars for the VCORCDP may come from any program within Vanderbilt University Medical Center (VUMC). Applications from outside the institution are encouraged, such as applicants from Meharry Medical College (MMC), but the applicant must hold an appointment (such as an adjunct) within one of the VUMC departments prior to entering the VCORCDP.
The majority of VCORCDP scholars come from core clinical oncology disciplines:
- Medical Oncology
- Pediatric Oncology
- Surgical Oncology
- Radiation Oncology
However, about 20% of applicants in the past 15 years have come from outside the classical clinical oncology disciplines, such as Pathology, Microbiology, and Immunology, Dermatology, Epidemiology, Cancer Biology, Urology, Pulmonary Medicine, and Neurology.
In addition, senior fellows or junior faculty from other non-oncology medical and surgical subspecialties (such as Geriatrics, Gastroenterology, Gynecology, Cardiology, and Otolaryngology) are potentially eligible for the VCORCDP, but the applicant’s proposed research must be directly related to cancer.
Research projects must fulfill the definition of patient-oriented research: “research conducted with human subjects (or material from human origin) for which an investigator directly interacts with human subjects.”
The Internal Advisory Committee selects applicants for support based on:
- The applicant's past educational and training history
- Their career goals as noted in the submitted personal statement
- Their dedication to a research career in clinical oncology, which will be based on their past record of involvement, their personal statement, and letters from references
- The letter of recommendation by the trainee’s proposed mentor
- The Internal Advisory Committee’s assessment of the potential benefit for career development for each applicant.
Appointees will be designated Paul Calabresi Scholars. The Committee will also make efforts to recruit candidates from underrepresented groups and disadvantaged backgrounds.
All scholars are selected based on a proposed research plan that includes:
- A VCORCDP mentor who is an actively practicing physician participating in patient-oriented cancer research
- or -
- A dyad mentorship in which at least one mentor is a clinical investigator and the other a basic or translational science investigator.
The proposed research project for the scholar must be patient-oriented and involve direct patient assessment, measurements on patient-derived samples, and/or the use of investigational therapeutic or diagnostic techniques.
Scholars are expected to complete the following VCORCDP core requirements during their time in the program, including:
- Complete Responsible Conduct of Research (RCR) training and to recognize and document RCR training occurring throughout the period of training
- Receive instruction in Methods of Enhancing Reproducibility
- Publish at minimum one peer-reviewed manuscript during the period of training
- Apply for at least one external source of funding during annually
Scholars and mentors must provide program evaluation in the form of:
- An annual structured written progress report, including a report of the mentor and mentoring committees, collected via a secure REDCap survey tool
- An annual Individual Development Plan (IDP), also collected via REDCap survey, with signoff by one or both program directors
- Participation in the annual retreat, including presentation of future direction in a chalk talk-style format
At the heart of VCORCDP is the mentored research project, and the availability of committed, experienced faculty mentors remains a strength of the program. Our faculty mentors represent diverse disciplines of oncology and their expertise spans the three major domains of research in which our scholars conduct their training and investigations:
- Clinical Trials and Drug Development
- Translational Cancer Biology
- Cancer Health Outcomes and Epidemiology
Mentors and areas of expertise:
Clinical Trials and Drug Development
Vandana G. Abramson, MD
Jordan D. Berlin, MD
Marta A. Crispens, MD
Cathy Eng, MD
Michael K. Gibson, MD, PhD
Laura Goff, MD, MSCI
Douglas B. Johnson, MD, MSCI
Christine Lovly, MD, PhD
Brian I. Rini, MD
Michael R. Savona, MD
Translational Cancer Biology
Justin M. Balko, PharmD, PhD
David K. Cortez, PhD
Nancy J. Cox,PhD
Michael L. Freeman, PhD
James R. Goldenring, MD, PhD
Scott W. Hiebert, PhD
Paula J. Hurley, PhD
Ian Macara, PhD
Ben Ho Park, MD, PhD
Jennifer A. Pietenpol, PhD
Jeffrey Rathmell, PhD
W. Kimryn Rathmell, MD, PhD
Ann Richmond, PhD
William P. Tansey, PhD
Christopher S. Williams, MD, PhD
Sandra Zinkel, MD, PhD
Cancer Outcomes and Epidemiology
Melinda Aldrich, PhD
Daniel A. Barocas,MD, MPH
Debra Friedman, MD, MS
John Graves, PhD
Tuya Pal, MD
David Penson, MD, MPH
Xiao-Ou Shu, MD, PhD, MPH
Martha Shrubsole, PhD
Georgia Wiesner, MD, MS
Consuelo H. Wilkins, MD, MSCI
Wei Zheng, MD, PhD, MPH
The major function of the VCORCDP Internal Advisory Committee (IAC) is to provide continuous oversight and advice regarding program operations. The IAC is chaired by program co-director, Dr. Debra Friedman, MD, MS, of the Vanderbilt University Medical Center Division of Pediatric Hematology & Oncology.
Specifically, the IAC:
- Screens and selects candidates for program participation
- Assists in the mentor selection process
- Reviews and approves each scholar’s cancer research career development plan
- Evaluates each scholar’s progress every six months to make necessary improvements and/or to recommend termination
- Evaluates the participation and success of faculty mentors
- Promotes the transition of scholars to extramural mechanisms of support and independence
- Evaluates the overall effectiveness of the program in terms of the quality and availability of applicants, the effectiveness of mentors, the progress of scholars, the success of scholars following completion of the career development program, and the success of recruitment strategies in identifying qualified applicants with a focus on URM.
The IAC meets every six months to review program progress and to evaluate applicants and scholars. The IAC is comprised of investigators from each subspecialty of oncology from which most scholars apply. The Committee has also been constituted to reflect the racial and ethnic diversity of leadership in cancer research at Vanderbilt. All IAC members are experienced investigators who have a record of mentoring and research productivity as well as administrative leadership.
IAC Member/Credentials | Department/Division |
---|---|
Ronald Alvarez, MD | Department of Gynecologic Oncology |
David Barocas, MD, MS | Department of Urology |
Michael DeBaun, MD, MS | Division of Pediatric Hematology & Oncology |
Michael Freeman, PhD | Department of Radiation Oncology |
Scott Hiebert, PhD | Department of Biochemistry |
Vicki Keedy, MD, MSCI | Division of Hematology & Oncology |
Carrie L. Kitko, MD | Division of Pediatric Hematology & Oncology |
Kelvin Moses, MD, PhD | Department of Urology |
Tuya Pal, MD, MS | Division of Genetic Medicine |
Ben Ho Park, MD, PhD | Division of Hematology & Oncology |
David Penson, MD, MPH | Department of Urology |
W. Kimryn Rathmell, MD, PhD | Division of Hematology & Oncology |
Ann Richmond, PhD | Department of Cancer Biology |
Christopher Williams, MD, PhD | Division of Gastroenterology |
Karen Winkfield, MD, PhD | Department of Radiation Oncology |
The major function of the VCORCDP External Advisory Committee (EAC) is to provide input into the scientific direction of program, ensure the program is meeting national workforce needs, and monitor progress, accomplishments, and trajectory to further programmatic advancement. These EAC faculty are all oncology physician-scientists, leaders in oncology, and directors or associate directors of oncology K12 programs at their institutions.
EAC Member/Credentials | Division/Institution |
---|---|
Lucile Adams-Campbell, PhD | Medical Oncology, Georgetown University |
Irwin Bernstein, MD | Pediatric Oncology, Fred Hutchinson Cancer Research Center |
Susan Blaney, MD | Pediatric Oncology, Baylor College of Medicine |
Ramaswamy Govindan, MD | Medical Oncology, Washington University |
Michelle Heil, BS | Senior Manager, Hospital Systems, American Cancer Society |
Funmi Olopade, MD | Medical Oncology, University of Chicago |
Since the inception of the grant in 2001, 89% (48/54) of Vanderbilt Clinical Oncology Research Career Development Program graduates have remained in academia and/or clinical research positions and 85% (46/54) have peer-reviewed grant support, including clinical trials.
Since 2001, our scholars have published 1,764 manuscripts within 5 years of their appointment to the VCORCDP. They are contributing significantly to the design and conduct of high-impact clinical research that is advancing the field of oncology and improving outcomes for cancer patients.
Name/Credentials | Start Year | Division | Current Position |
---|---|---|---|
Briana Smith, MD | 2022 | Pediatric Oncology | Assistant Professor, Pediatric Hematology/Oncology, VUMC |
Sarah Nunnery, MD, MSCI | 2022 | Medical Oncology | Assistant Professor, Hematology/Oncology, VUMC |
Michael Topf, MD | 2022 | Otolaryngology | Assistant Professor, Hematology/Oncology, VUMC |
Kerry Schaffer, MD, MSCI | 2022 | Medical Oncology | Assistant Professor, Hematology/Oncology, VUMC |
Thatcher Heumann, MD, MPH | 2022 | Medical Oncology | Assistant Professor, Hematology/Oncology, VUMC |
Saara Kaviany, DO | 2020-21 | Pediatric Oncology | Instructor, Pediatric Hematology/Oncology, VUMC |
Sonya Reid, MD, MPH | 2020-21 | Medical Oncology | Assistant Professor, Hematology/Oncology, VUMC |
Rajiv Agarwal, MD, MSCI | 2019 | Medical Oncology | Assistant Professor of Medicine, Division of Hematology/Oncology, VUMC |
Kathryn Beckermann, MD, PhD | 2019 | Medical Oncology | Instructor of Medicine, Division of Hematology/Oncology, VUMC |
Joshua Donaldson, MD, PhD | 2019 | Medical Oncology | Instructor of Medicine, Division of Hematology/Oncology, VUMC |
Vivian Weiss, MD, PhD | 2019 | Pathology, Microbiology & Immunology | Assistant Professor of Medicine, Department of Pathology, Microbiology & Immunology, VUMCA Review of Low-Dose Radiotherapy for Osteoarthritis |
Satya Das, MD, MSCI | 2018 | Medical Oncology | Assistant Professor of Medicine, Division of Hematology/Oncology, VUMC |
Peter Hsu, MD, MPH | 2018 | Pediatric Oncology | Children's Hospital of Boston and Dana Farer Cancer institute |
Wade T. Iams, MD, MSCI | 2018 | Medical Oncology | Assistant Professor of Medicine, Division of Hematology/Oncology, VUMC |
Austin Kirschner, MD, PhD | 2018 | Radiation Oncology | Assistant Professor of Medicine, Division of Hematology/Oncology, VUMC |
Rachael R. Schulte, MD, MSCI | 2018 | Pediatric Oncology | Assistant Professor of Pediatrics, Section of Pediatric Hematology/Oncology, Indiana University School of Medicine |
Scott Haake, MD, PhD | 2017 | Medical Oncology | Assistant Professor of Medicine, Division of Hematology/Oncology, VUMC |
Myrick (Ricky) Shinall, Jr., MD, PhD | 2017 | Surgery | Assistant Professor, Division of General Surgery, VUMC |
Krystle Kuhs, PhD, MPH | 2017 | Epidemiology | Associate Professor, Department of Epidemiology, College of Public Health, University of Kentucky & co-leader of the Cancer Prevention and Control Research Program, Markey Cancer Center, Lexington, KY |
Valerie Jansen, MD, PhD | 2016 | Medical Oncology | Senior Medical Director, Mersana Therapeutics, Boston |
Eric Tkaczyk, MD, PhD | 2016 | Dermatology | Assistant Professor of Dermatology & Assistant Professor of Biomedical Engineering, VUMC |
Kelvin Moses, MD, PhD | 2015 | Urologic Surgery | Associate Professor, Department of Urology & Fellowship Director of the Urologic Oncology Fellowship, Division of Urologic Oncology, VUMC |
Clinton Carroll, MD, MSCI | 2014 | Pediatric Oncology | Pediatric Hematologic/Oncologist, TriStar Medical Group Children's Specialists, Nashville |
Stephen (Wes) Clark, MD, PhD | 2014 | Neurologic Surgery | Assistant Professor, Division of Neuro-Oncology, Department of Neurology, VUMC |
Marco Davilla, MD, PhD | 2014 | Medical Oncology | Associate Member in Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center |
P. Brent Ferrell, Jr., MD | 2014 | Medical Oncology | Assistant Professor of Medicine, Division of Hematology/Oncology, VUMC |
Ariella Hanker, PhD | 2014 | Cancer Biology | Assistant Professor of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center |
Christy Osgood, MD | 2014 | Pediatric Oncology | Medical Officer, U.S. Federal Food and Drug Administration |
Kamran Idrees, MD, MSCI, MMHC | 2013 | Surgical Oncology | Associate Professor of Surgery, Chief, Division of Surgical Oncology and Endocrine Surgery, Director, Pancreas and GI Surgical Oncology, and Director, Peritoneal Surface Malignancy/HIPEC Program, VUMC |
Douglas Johnson, MD, MSCI | 2013 | Medical Oncology | Associate Professor, Division of Hematology/Oncology, Department of Medicine |
Shanna Arnold, PhD, MSCI | 2012 | Pathology | Lead Oncology Investigator, Outcomes Research Program, Sarah Cannon Research Institute |
Kristen Ciombor, MD, MSCI | 2012 | Medical Oncology | Assistant Professor, Division of Neuro-Oncology, Department of Neurology, VUMC |
Adam Esbenshade, MD, MSCI | 2012 | Pediatric Oncology | Associate Professor, Division of Pediatric Hematology/Oncology, VUMC |
Christine Lovly MD | 2012 | Medical Oncology | Co-leader, Translational Research and Interventional Oncology Research Program & Ingram Associate Professor of Medicine, Division of Hematology/Oncology, VUMC |
Laura McGirt, MD, MSCI | 2012 | Dermatology | Director of Dermatologic Oncology, Levine Cancer Institute |
Eric Liu, MD, MSCI | 2011 | Surgical Oncology | Neuroendocrine Specialist and Surgeon, Rocky Mountain Cancer Centers, Denver |
Philip Lammers,MD, MSCI | 2011 | Medical Oncology | Medical Director of Clinical Oncology Research, Baptist Cancer Center, Memphis, & Adjunct Assistant Clinical Professor, VUMC |
Kirk (Pat) KeeganMD, MPH | 2011 | Urology | Assistant Professor, Department of Urology & Chief, Urology Section of Nashville VA Division of Urologic Oncology, VUMC |
Anna Vilgelm, MD, PhD | 2011 | Cancer Biology | Assistant Professor, Translational Therapeutics, Ohio State University School of Medicine |
Leora Horn, MD, MSc | 2009 | Medical Oncology | Ingram Associate Professor of Cancer Research, Associate Professor of Medicine, Division of Hematology/Oncology, Assistant Director of Educator Development Program & Clinical Director of Thoracic Oncology Program, VUMC |
Joshua Mondschein, MD, MSCI | 2009 | Radiation Oncology | Radiation Oncologist,Tennessee Oncology, Franklin, TN |
Kenneth Niermann, MD, MSCI | 2008 | Radiation Oncology | Assistant Professor, Department of Radiation Oncology, VUMC |
Nishitha Reddy, MD, MSCI | 2008 | Medical Oncology | Assistant Professor, Department of Radiation Oncology, VUMC |
Vicki Keedy, MD, MSCI | 2007 | Medical Oncology | Associate Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Clinical Director of Sarcoma & Medical Director of Clinical Trials office, VUMC |
Stephen Strickland, MD, MSCI | 2007 | Medical Oncology | Assistant Professor of Medicine, Division of Hematology/Oncology & Service Line Chief of Heme Malignancies, VUMC |
Pinki Prasad, MD, MPH | 2007 | Pediatric Oncology | Associate Professor of Pediatrics, Department of Pediatrics, Louisiana State University Health: New Orleans |
Brian Engelhardt, MD, MSCI | 2006 | Medical Oncology | Associate Professor of Medicine, Division of Hematology/Oncology, VUMC |
Alex Parikh, MD, MPH | 2006 | Surgical Oncology | Robert and Penny Barnhill Distinguished Professor of Oncology, Chief of Division of Surgical Oncology & Director of Hepatobiliary and Pancreatic Surgery, East Carolina University Brody School of Medicine |
Laura Williams Goff, MD, MSCI | 2006 | Medical Oncology | Executive Medical Director of the VICC Cancer Patient Center, VUMC |
Igor Puzanov, MD, MSCI | 2004 | Medical Oncology | Clinical Professor of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo & Professor & Director of Early Phase Clinical Trials Program, Department of Medicine, Roswell Park Comprehensive Cancer Center |
Catherine Jones, MD, MSCI | 2004 | Medical Oncology | Medical Oncologist, Mercy Medical Center, Senora, CA |
Sunil Geevarghese, MD, MSCI | 2004 | Surgical Oncology | Program Director of Vanderbilt ASTS Transplant Surgery Fellowship & Associate Professor of Surgery, Radiology and Radiological Sciences, VUMC |
Madan Jagasia, MD | 2004 | Medical Oncology | Senior Vice President Medical Affairs, Iovance Biotherapeutics, Inc., San Carlos, CA |
Jennifer Domm, MD, MSCI | 2004 | Pediatric Oncology | Pediatric Hematologist/Oncologist & Medical Director, TriStar Medical Group Children's Specialists & Vice Chair, Department of Pediatrics, The Children's Hospital at TriStar Centennial |
Charles Leys, MD, MSCI | 2003 | Surgical Oncology | Associate Professor of Surgery, Chief of Division of Pediatric Surgery and Dr. James and Sharon Gutenberger Family Pediatric Surgery Chair, University of Wisconsin |
Tanyanika Phillips, MD, MPH | 2002 | Geriatric Oncology | Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope Cancer Center, Lancaster, CA |
Carl Schmidt, MD, MSCI | 2002 | Surgical Oncology | Professor and Chief of Surgical Oncology, West Virginia University |
Richard HO, MD, MSCI | 2001 | Pediatric Oncology | Associate Professor of Pediatrics, VUMC |
Julie Means-Powell, MD, MSCI | 2001 | Medical Oncology | Medical Oncologist, Tennessee Oncology, Nashville |
Stacy Moulder, MD, MSCI | 2001 | Medical Oncology | Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston |
Thank you for your interest in the VCORCDP program. The next deadline for submitting an application is March 1, 2024.
Applications should include:
- Three-to-five-page research proposal
- Letter from the potential mentors (two mentors are recommended, one of which must be a member of the training grant) agreeing to mentor the applicant and commenting on the applicant’s potential and the likelihood of success of the research project
- Curriculum vitae
- Letter from the applicant’s department chair or division director indicating support, including guarantee of protected time
- Personal statement from the applicant indicating career goals, planned didactic coursework, and commitment to oncology research
Please contact Kimryn Rathmell or Deb Friedman with questions about the application process or the training program.
Interested applicants should e-mail Lucy Shaffer at lucy.d.shaffer@vumc.org prior to submitting an application. Send completed applications to her by March 1, 2024.
Interested applicants can set up a meeting with VCORCDP program leaders Drs. Friedman, Hurley and/or Rathmell to review details of the program and application process.
Program Leadership
Debra Friedman, MD
Professor of Pediatrics
Co-Director, VCORCDP
Paula Hurley, PhD
Associate Professor of Medicine
Co-Director, VCORCDP